HIV Ireland. (2019) HIV Ireland annual report 2018. Dublin: HIV Ireland.
Preview | Title | Contact |
---|---|---|
|
PDF (HIV Ireland annual report 2018)
- Published Version
5MB |
HIV Ireland is contributing to the implementation of a number of national and international health strategies and relevant policies including Healthy Ireland: A Framework for Improved Health and Wellbeing 2013-2025, The National Sexual Health Strategy 2015-2020, Reducing Harm Supporting Recovery: A health-led response to drug and alcohol use in Ireland 2017-2025,
Our Community HIV and STI Testing Service in Dublin operates in our building and is run in conjunction with the GUIDE Clinic (St. James’s Hospital). It is a low-threshold service, underpinned by a street outreach service which targets at-risk communities. During the registration process, participants are given an anonymous profile form to complete on their personal smart phones or on tablets provided by HIV Ireland; this allows us to ascertain unique information on those coming in for testing, giving us an overall picture, and profile, of our testing participants. 2% (n=11) identified as having experienced IV drug use.
(p.8) When asked about drugs taken before or during sex, 8% (n=40) had taken Poppers, 4% (n=22) of participants had taken GHB (known also as ‘G’), 1% (n=5) had taken Crystal Meth and a further 1% (n=5) had taken Mephedrone (also known as ‘M-CAT’).
G Health and disease > Disease by cause (Aetiology) > Communicable / infectious disease > HIV
J Health care, prevention, harm reduction and treatment > Health related issues > Health information and education > Communicable / infectious disease control
J Health care, prevention, harm reduction and treatment > Health related issues > Health information and education > Communicable / infectious disease control > Safe sex / sexual health
T Demographic characteristics > Person who injects drugs (Intravenous / injecting)
VA Geographic area > Europe > Ireland
Repository Staff Only: item control page